Work

Evolocumab (PCSK9 Inhibitor) in Hereditary Spastic Paraplegia Type 5

Year: 2020

Type: preprint

Study design: Clinical Trial

Source: SSRN Electronic Journal

DOI: 10.2139/ssrn.3569873

Authors: Ying Fu, Xiang Lin, Yi-Jun Chen, Lu-Lu Lai, Yi Lin, Meng-Wen Wang, Sin Man Lam, Yi-Heng Zeng, Xiao-Hong Lin, Yun-Lu Li, Ji-Ting Zhu, Hai-Zhu Chen, Gui-He Li, Xue-Jing Huang, Zhi-Yuan Zhao, Qi-Qi Wang, Guanghou Shui, Ning Wang, Wan-Jin Chen

Institutions: Fujian Medical University, First Affiliated Hospital of Fujian Medical University, Chinese Academy of Sciences, State Key Laboratory of Molecular Developmental Biology

Language: English

Topic: Hereditary Neurological Disorders

Subfield: Cellular and Molecular Neuroscience

Field: Neuroscience

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W3210757706

Cites:

Cited by: 1

Related to: 10